Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |